Abstract: A reactor is provided with a coil including a pair of winding portions arranged in parallel, a magnetic core to be arranged inside and outside the winding portions, a case for accommodating an assembly including the coil and the magnetic core, a leaf spring fitting for pressing the assembly toward an inner bottom surface of the case, and a sealing resin portion to be filled into the case. Each of the winding portions is so arranged that an arrangement direction of the winding portions is along a depth direction of the case. The case includes an opening having a rectangular planar shape. The leaf spring fitting is arranged in a state curved toward the inner bottom surface by having both end parts of the leaf spring fitting directly pressed against parts of inner wall surfaces of the case facing each other in a long side direction.

Abstract: A reactor includes a coil having a winding portion; a magnetic core; and a case. The magnetic core includes a plurality of core pieces forming a closed magnetic circuit. The core pieces include two outer core pieces having a portion disposed outside the winding portion. The case includes a first and a second opposing faces are respectively opposed to outer edge faces of the outer core pieces, and a case inclined surface provided on at least one of the first and the second opposing faces. The case inclined surface is inclined such that a distance between the first opposing face and the second opposing face decreases from an opening side of the case toward an inner bottom face of the case, and a core inclined surface on the outer edge face side of the outer core piece is in surface contact with the case inclined surface.

Abstract: An imaging apparatus, imaging system, and imaging method enabling restoration of image according to a plurality of optical systems by one apparatus, having a plurality of imaging apparatuses 100A to 100C each having an optical system 110, phase plate (optical wavefront modulation element) 120, imaging element 130 able to capture an object aberration image passing through the optical system 110 and phase plate 120, imaging apparatus side storage portion 140 storing coefficient specifying information for specifying a convolution coefficient, and transmission device 150 transmitting object aberration image data obtained from the imaging element 130 and the coefficient specifying information stored in the storage portion 140; and a processing device 200 acquiring one coefficient from among a plurality of convolution coefficients stored in advance based on coefficient specifying information in accordance with a zoom position or zoom amount transmitted from the imaging apparatus 100, and generating dispersion-free

Abstract: Methods of the present invention for producing dibromofluorobenzene derivatives (compounds II) comprise Step 1, in which compounds (I) having the following general formula (I): (wherein, R1 and R2 each independently represent a C1-6 alkyl group) are reacted in a solvent with a brominating reagent.

Abstract: 4-(Substituted phenyl)hexahydropyrido[2,1-c][1,4]oxazin-6-one represented by formula (I) or a salt thereof is useful as an intermediate for the production of a bicyclic cinnamide compound which is an A? production inhibitor. 4-(Substituted phenyl)hexahydropyrido[2,1-c][1,4]oxazin-6-one or the salt thereof can be produced in an industrially advantageous manner by subjecting a compound represented by formula (II) or a salt thereof to an intramolecular condensation reaction.

Abstract: The present invention is related to compounds represented by the following formula, or salts or hydrates thereof wherein, T1 represents a 4- to 12-membered heterocyclic group containing one or two nitrogen atoms in the ring, which is a monocyclic or bicyclic structure that may have one or more substituents; X represents a C1-6 alkyl group which may have one or more substituents, or such; Z1 and Z2 each independently represent a nitrogen atom or a group represented by the formula —CR2—; R1 and R2 independently represent a hydrogen atom, a C1-6 alkyl group which may have one or more substituents, or a C1-6 alkoxy group which may have one or more substituents, or such. These are novel compounds that exhibit an excellent DPPIV-inhibiting activity.

Abstract: An imaging apparatus, imaging system, and imaging method enabling restoration of image according to a plurality of optical systems by one apparatus, having a plurality of imaging apparatuses 100A to 100C each having an optical system 110, phase plate (optical wavefront modulation element) 120, imaging element 130 able to capture an object aberration image passing through the optical system 110 and phase plate 120, imaging apparatus side storage portion 140 storing coefficient specifying information for specifying a convolution coefficient, and transmission device 150 transmitting object aberration image data obtained from the imaging element 130 and the coefficient specifying information stored in the storage portion 140; and a processing device 200 acquiring one coefficient from among a plurality of convolution coefficients stored in advance based on coefficient specifying information in accordance with a zoom position or zoom amount transmitted from the imaging apparatus 100, and generating dispersion-free

Abstract: An imaging apparatus and an image processing method able to simplify an optical system, able to reduce costs, able to obtain an image blurred only in a background by a single imaging operation, and able to obtain a restored images with little influence of noise, wherein a signal processing portion formed by an image processing device 140 etc.

Abstract: A biometric authentication apparatus having a simple configuration, able to easily focus on a fingerprint or a vein or other blood vessel pattern and able to clearly capture an image of the same, able to prevent forgery, and in addition able to realize high precision authentication, which biometric authentication apparatus 100 having a transparent plate 110 formed by for example glass or plastic for placement of the finger of the authenticated person, that is, the inspected specimen OBJ, downward in the figure (surface where fingerprint is located facing downward), a fingerprint capturing use illumination apparatus 120, a vein capturing use illumination apparatus 130, and an image capturing apparatus 140, which image capturing apparatus 140 has an imaging lens apparatus capturing a dispersed image of an object passing through the optical system and phase plate, an image processing apparatus generating a dispersion-free image signal from a dispersed image signal from the imaging element, and an object approxim

Abstract: A compound (8) represented by the formula: (8) wherein R1 represents a 6- to 14-membered aromatic hydrocarbon ring group which may have a substituent; and n represents 0 to 2, can be produced with good efficiency by reacting a compound (3) represented by the formula: (3) wherein R1 and n are as defined above; and Q represents a single bond or —CH(Y)— where Y represents a hydrogen atom or a C1-6 alkyl group] with 3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzaldehyde in the presence of a base.

Abstract: The objective of this invention is to provide novel compounds that show excellent DPPIV-inhibiting activity. The present invention provides compounds represented by the general formula (I), salts thereof, or hydrates thereof, [wherein, T1 stands for a monocyclic or bicyclic 4 to 12-membered heterocycle having 1 or 2 nitrogen atoms in the ring, which may have substituents; in formula (I), the following formula represents a double bond or a single bond; X3 denotes an oxygen atom or a sulfur atom; X1 denotes a C2-6 alkyl group which may have substituents; Z1 denotes a nitrogen atom or the formula —CR3=; Z2 and Z3 each independently denote a nitrogen atom, the formula —CR1=, a carbonyl group, or the formula —NR2—; R1, R2, R3, and X2 each independently denote a C1-6 alkyl group which may have substituents, and such].

Abstract: The present invention is related to compounds represented by the following formula, or salts or hydrates thereof wherein, T1 represents a 4- to 12-membered heterocyclic group containing one or two nitrogen atoms in the ring, which is a monocyclic or bicyclic structure that may have one or more substituents; X represents a C1-6 alkyl group which may have one or more substituents, or such; Z1 and Z2 each independently represent a nitrogen atom or a group represented by the formula —CR2—; R1 and R2 independently represent a hydrogen atom, a C1-6 alkyl group which may have one or more substituents, or a C1-6 alkoxy group which may have one or more substituents, or such. These are novel compounds that exhibit an excellent DPPIV-inhibiting activity.

Abstract: A compound represented by the following formula (1): wherein R represents a 4-fluorophenyl group and the like; Q represents —CH(CH3)— and the like; and n represents 1 and the like and a pharmaceutically acceptable salt thereof can be prepared in one-pot by reacting a compound represented by the following formula (2): wherein R1 represents a 4-fluorophenyl group and the like; and Q and n have the same meaning as described above, with 3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzaldehyde in the presence of a base and, if necessary, removing a protecting group.

Abstract: Disclosed is a method for producing a dibromofluorobenzene derivative (compound II) comprising a step 1 wherein a compound (I) represented by the general formula (I) below is reacted with a brominating agent in a solvent. (I) (II) (In the formulae, R1 and R2 independently represent a C1-6 alkyl group.

Abstract: An imaging apparatus, and method, enabling lens design without regard to an object distance and a defocus range and enabling image restoration by high precision processing, has an image lens device 200 for capturing a dispersed image of an object passing through an optical system and a phase plate serving as an optical wavefront modulation element, an image processing device 300 for generating a dispersion-free image signal from a dispersed image signal from the imaging element 220, and an object schematic distance information detection device 400 for generating information corresponding to the distance up to the object, wherein the image processing device 300 generates a dispersion-free image signal from the dispersed image signal based on the information generated by the object schematic distance information detection device 400.

Abstract: The present invention relates to use of 1-carbamoylazole derivatives as medicaments and pharmaceutical compositions containing 1-carbamoylazole derivatives as the active ingredient, based on their DPPIV inhibiting effects.

Abstract: An excellent squalene synthase inhibitor is provided. Specifically, what is provided is a compound (I) represented by the following formula, a salt thereof or a hydrate of them. In formula (I), R1 represents an optionally substituted vinyl group or an aromatic ring which may be substituted. Also, n is an integer of 0 to 2. Further, X, Y and Z are the same as or different from each other and each represents an optionally substituted carbon atom, or an optionally substituted nitrogen atom, sulfur atom or oxygen atom, and Y optionally represents a single bond, and when Y represents the single bond, the ring to which X, Y and Z belong is a 5-membered ring. Also in the formula, CyA represents a 5- to 14 membered non-aromatic cyclic amino group or non-aromatic cyclic amido group which may be substituted, and the non-aromatic cyclic amino group or the non-aromatic cyclic amido group optionally having an oxygen atom or a sulfur atom.

Abstract: The present invention provides novel compounds exhibiting an excellent DPPIV inhibition effect. The compounds are represented by the formula: wherein, m is 0 or 1; n is 0; R31, R32, R33, R34, R35, R36, R37, R38, R39, R40, R41, and R42 each represent a hydrogen atom; X represents an alkynyl group, an aryl group, and such, which group may be substituted; and, R1 and R2 each independently represents a hydrogen atom, an alkyl group, an alkoxyl group, or such, or salts or hydrates thereof.

Abstract: The objective of this invention is to provide novel compounds that show excellent DPPIV-inhibiting activity. The present invention provides compounds represented by the general formula (I), salts thereof, or hydrates thereof, [wherein, T1 stands for a monocyclic or bicyclic 4 to 12-membered heterocycle having 1 or 2 nitrogen atoms in the ring, which may have substituents; in formula (I), the following formula represents a double bond or a single bond; X3 denotes an oxygen atom or a sulfur atom; X1 denotes a C2-6 alkyl group which may have substituents; Z1 denotes a nitrogen atom or the formula —CR3?; Z2 and Z3 each independently denote a nitrogen atom, the formula —CR1?, a carbonyl group, or the formula —NR2—; R1, R2, R3, and X2 each independently denote a C1-6 alkyl group which may have substituents, and such].

Abstract: The present invention provides a preventive or therapeutic agent of a new type for diabetes mellitus and diabetic complications on the basis of an adenosine A2 receptor antagonist action. A purine compound represented by the formula (I), its pharmacologically acceptable salt or hydrates thereof has an adenosine A2 receptor antagonistic action and is useful for prevention or therapy of diabetes mellitus and diabetic complications. In addition, adenosine A2 receptor antagonists having different structures from those of the compounds described above, for example KW6002, are also effective for prevention or therapy of diabetes mellitus and diabetic complications. In the formula, W is —CH2CH2—, or —CH?CH— or —C?C—; R1 is: (in the formula, X is hydrogen atom, hydroxyl group, a lower alkyl group, a lower alkoxy group, etc.; and R5 and R6 are the same as or different from each other and each represents hydrogen atom, a lower alkyl group, a cycloalkyl group, etc.) and the like; R2 is an amino group, etc.